1. Home
  2. LFCR

as 07-26-2024 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.

Founded: 1986 Country:
United States
United States
Employees: N/A City: CHASKA
Market Cap: 161.1M IPO Year: N/A
Target Price: $9.50 AVG Volume (30 days): 304.0K
Analyst Decision: Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -3.32 EPS Growth: N/A
52 Week Low/High: $4.47 - $11.46 Next Earning Date: 08-29-2024
Revenue: $103,269,000 Revenue Growth: -7.19%
Revenue Growth (this year): 23.86% Revenue Growth (next year): 15.39%

LFCR Daily Stock ML Predictions

Share on Social Networks: